Literature DB >> 25756300

Chemically-Modified Peptides Targeting the PDZ Domain of GIPC as a Therapeutic Approach for Cancer.

Chitta Ranjan Patra, Chamila N Rupasinghe, Shamit K Dutta, Santanu Bhattacharya, Enfeng Wang, Mark R Spaller, Debabrata Mukhopadhyay.   

Abstract

Entities:  

Year:  2015        PMID： 25756300      PMCID： PMC5305656          DOI： 10.1021/cb500865a

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN： 1554-8929            Impact factor:   5.100


× No keyword cloud information.
  1 in total

1.  Chemically modified peptides targeting the PDZ domain of GIPC as a therapeutic approach for cancer.

Authors:  Chitta Ranjan Patra; Chamila N Rupasinghe; Shamit K Dutta; Santanu Bhattacharya; Enfeng Wang; Mark R Spaller; Debabrata Mukhopadhyay
Journal:  ACS Chem Biol       Date:  2012-02-15       Impact factor: 5.100
  1 in total
  1 in total

1.  Synectin promotes fibrogenesis by regulating PDGFR isoforms through distinct mechanisms.

Authors:  Mary C Drinane; Usman Yaqoob; Haibin Yu; Fanghong Luo; Thomas Greuter; Juan P Arab; Enis Kostallari; Vikas K Verma; Jessica Maiers; Thiago Milech De Assuncao; Michael Simons; Debabrata Mukhopadhyay; Tatiana Kisseleva; David A Brenner; Raul Urrutia; Gwen Lomberk; Yandong Gao; Giovanni Ligresti; Daniel J Tschumperlin; Alexander Revzin; Sheng Cao; Vijay H Shah
Journal:  JCI Insight       Date:  2017-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.